Syros Pharmaceuticals (SYRS) Announces Encouraging Initial D

Syros Pharmaceuticals (SYRS) Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine

Syros Pharmaceuticals (SYRS) Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Azur , Aquitaine , France , Thomas Cluzeau , Davida Roth , Syros Pharmaceuticals , Head Of Hematology At Nice University Hospital , Dazur University , Regimen Continues , Demonstrate Favorable , Data Expected , Host Conference Call , Nice University Hospital , Chief Medical Officer ,